CD90.2 Antibody (53-2.1) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-43987
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Rat IgG2a Kappa Clone # 53-2.1
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen for this antibody was CD90.2.
Reactivity Notes
This antibody is reactive to Mouse.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2a Kappa
Scientific Data Images for CD90.2 Antibody (53-2.1) [FITC]
Flow Cytometry: CD90.2 Antibody (53-2.1) [FITC] [NBP1-43987] - Staining of mouse splenocytes with Anti-Mouse CD90.2 (Thy-1.2) FITC (left ) or PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.
Applications for CD90.2 Antibody (53-2.1) [FITC]
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Application Notes
The 53-2.1 antibody has been tested by flow cytometric analysis of mouse splenocyte suspensions. This can be used at less than or equal to 0.06 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8cells/test.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.2) with 0.1% gelatin
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD90.2
Alternate Names
CD90, CD90 antigen, CDw90, FLJ33325, Thy-1 antigen, Thy-1 cell surface antigen, thy-1 membrane glycoprotein, Thy-1 T-cell antigen
Gene Symbol
THY1
Additional CD90.2 Products
Product Documents for CD90.2 Antibody (53-2.1) [FITC]
Product Specific Notices for CD90.2 Antibody (53-2.1) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...